Skip to content

Heavy Menstrual Bleeding

Effect of Dracaena Cinnabari (Dam-ul- Aqwain)on Menstrual Flow in Menorrhagia-A Randomized Control Clinical Study. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/02/062521
Enrollment
60
Registered
2024-02-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N920- Excessive and frequent menstruation with regular cycle Health Condition 2: N926- Irregular menstruation, unspecified Health Condition 3: N925- Other specified irregular menstruation

Interventions

Intervention1: Dracaena Cinnabari(Dam-ul-Aqwain): Oral administration of Dam-ul-aqwain sufoof 1gm twice a day for 5 days Control Intervention1: Tranexamic acid 5oomg: Tab.Tranexamic acid 500 mg twice

Sponsors

Pg Department of Obstetrics and Gynaecology(Ilmul Qabalat Wa Amraz-E- Niswan)
Lead Sponsor
Government Nizamia Tibbi College and General Hospital Charminar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1.Excessive bleeding moreover than 80ml 2.Both married Nulliparous multiparous) unmarried. 3.Fibroid (less than 3cm),anovulatory,unknown etiology. 4.Thyroid disorders. Patient willing to comply various demand of study.

Exclusion criteria

Exclusion criteria: 1.Patients with HTN,DM 2.Significant Cardiovascular/pulmonary,Hepato-renal dysfunction. 3.Hematological disorders 4.Attained menopause 5.Known causes of immune-compromised state(AIDS/Malignancies,Auto immune disease)

Design outcomes

Secondary

MeasureTime frame
Menstrual Blood Flow is Decreased/StoppedTimepoint: Each Patients Outcome Depends on Consumption of Interventions for 5 days BD

Primary

MeasureTime frame
Pictorial Blood Picture Chart.Timepoint: Amount of Blood Loss in Each Menstrual Cycle

Countries

India

Contacts

Public ContactKhujasta Jabeen

Govt. Nizamia Tibbi College And General Hospital

syedaabidunnisa@gmail.com9492027082

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026